Trading Signals: LGND Stock Price Prediction and Forecast (Mon. Aug. 10, 2015 - Wed. Sep. 27, 2023)(Ligand Pharmaceuticals Inc)
| LGND latest price $122.3950 (-0.77%) ($122.3950 - $122.3950) on Fri. May. 21, 2021. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 3.42% (three month average) | RSI | 29 | Latest Price | $122.3950(-0.77%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | LGND declines -1.1% a day on average for past five trading days. | Weekly Trend | LGND declines -3.6% a week on average for past two weeks. | Market Behavior | Rotation from growth to value for large cap. Value stock rally for small cap. | Correlated ETFs | Broad market will support LGND advance at 0% a week (0% probability) IBB(58%) IWO(57%) IWM(54%) IWC(52%) XBI(51%) | Factors Impacting LGND price | LGND will decline at least -1.71% in a week (0% probabilities). VIXM(-27%) VXX(-17%) UUP(-17%) IGOV(-6%) UNG(-3%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -1.71% (StdDev 3.42%) | Hourly BBV | 0.7 () | Intraday Trend | 0% | | | |
|
1 - 5 Day Possible Target | $112.73(-7.9%) | Resistance Level | $132.12 | 5 Day Moving Average | $122.91(-0.42%) | 10 Day Moving Average | $124.93(-2.03%) | 20 Day Moving Average | $132.12(-7.36%) | To recent high | -26.2% | To recent low | 1.9% | Market Cap | $1.967b | | | | Ligand Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the development and acquisition of technologies that help pharmaceutical companies to discover and develop medicines. Its products include evomela, IV voriconazole, duavee, viviant/conbriza, nexterone, and noxafil-IV. The company was founded by Ronald M. Evans in 1987 and is headquartered in San Diego, CA. |